EagleClaw Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
EagleClaw Capital Management's MDT Position: Q2 2026 in Review
EagleClaw Capital Management increased its Medtronic (MDT) stake by 107% in Q2 2026, buying an estimated $2.83M and bringing the position to 67,845 shares worth $5.31M. The position accounts for 0.71% of the portfolio, ranked #46.
EagleClaw Capital Management first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- EagleClaw Capital Management held 67,845 shares of Medtronic worth $5.31M as of Q2 2026.
- EagleClaw Capital Management bought 35,098 Medtronic shares in Q2 2026, an estimated $2.83M.
- Medtronic made up 0.71% of EagleClaw Capital Management's portfolio in Q2 2026, its #46 holding.
- EagleClaw Capital Management first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.